1. Home
  2. All topics: A to Z
  3. Antimicrobial consumption
  4. Surveillance and disease data
  5. Antimicrobial consumption database
  6. Country overview

Country overview of antimicrobial consumption

DAMC06
 
Antimicrobial consumption in Austria, 2019
Data source
  
Health care
Data type
Coverage*
Data source (consumption)
Population
(under surveillance)
Data source (population)
Community (primary care sector)
Reimbursement
100%
Health Insurance Company
8 858 775
Eurostat
* Proportion of total country population under surveillance.
Antibacterials for systemic use (ATC group J01)
Consumption of antibacterials for systemic use (ATC group J01) in the community (primary care sector) and the hospital sector expressed in DDD per 1000 inhabitants and per day in 2019
ATC group J01
Community
(primary care sector)
Hospital sector
Beta-lactam antibacterials, penicillins (J01C)
4.75
-
Other beta-lactam antibacterials (J01D)
1.39
-
Tetracyclines (J01A)
0.32
-
Macrolides, lincosamides and streptogramins (J01F)
2.13
-
Quinolone antibacterials (J01M)
0.73
-
Sulfonamides and trimethoprim (J01E)
0.22
-
Other J01 substances
0.38
-
Total
9.91
-
Antimycotics and antifungals for systemic use (ATC groups J02 & D01BA)
Consumption of antimycotics and antifungals for systemic use (ATC groups J02 & D01BA) in the community (primary care sector) and the hospital sector expressed in DDD per 1000 inhabitants and per day in 2019
ATC groups J02 & D01BA
Community
(primary care sector)
Hospital sector
Terbinafine (D01BA02)
0.52
-
Amphotericin B (J02AA01)
<0.01
-
Ketoconazole (J02AB02)
0.00
-
Fluconazole (J02AC01)
0.09
-
Itraconazole (J02AC02)
0.14
-
Voriconazole (J02AC03)
<0.01
-
Other substances
0.01
-
Total
0.77
-
Comments
 
General comments for comparison of antimicrobial consumption data from different countries and/or years:
Total care includes data both from the hospital sector and community (primary care sector) and overestimates the figures when used for reporting for the community sector.
Some countries report reimbursement data that do not include consumption of antimicrobials obtained without prescription and other non-reimbursed courses.
For more information please see the report "Data source overview of antimicrobial consumption"
This report has been generated from ESAC-Net data submitted to TESSy, The European Surveillance System on 2020-11-26. The report reflects the state of submissions in TESSy as of 2020-11-26 at 18:30